NFONF yields 9.26% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 7
Combined, NFONF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NFONF + MRK for your $10,000?
NFON AG provides cloud-based telecommunication services to business customers in Germany, Austria, Italy, the United Kingdom, Spain, France, and Portugal. It offers Cloudya and centrexx products for customers with the required brokerage service from the cloud in its data centers through the cloud private branch exchange; and telephone conference services. The company also provides various solutions, such as Nconnect voice for IP communications; Nconnect data, which allows Internet access; Ncontactcenter, a cloud contact centre solution, that facilitates customer support for various channels, agents, and locations; Nhospitality, which integrates cloud telephony into property management systems for hotel industry; Neorecording that allows companies to record conversations and retain them in a tamper-proof and encrypted environment; Nmonitoring Queues to monitor and track internal work performance; and Noperatorpanel, which provides a professional voice reception panel for customers to receive incoming calls and forward certain calls to their intended recipients. In addition, its product portfolio includes unified communications and collaboration, such as Meet and Share; integration for Microsoft Teams; and business applications comprising CRM Connect, as well as sells devices, such as telephones, soft clients for PCs and smartphones, and related software. The company has an agreement with Meetecho. NFON AG was founded in 2007 and is headquartered in Munich, Germany.
Full NFONF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.